XenoPort's Series C Round

XenoPort raised a round of funding on February 10, 2004.

XenoPort (NASDAQ: XNPT) is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to …

Articles about XenoPort's Series C Round: